Predictors of the development of febrile neutropenia in chemotherapy for advanced germ cell tumors

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

(2019) Timothy Gilligan et al.   Journal of the National Comprehensive Cancer Network

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors

(2018) Angelika Terbuch et al.   Cancer Medicine

Identification of risk factors predicting febrile neutropenia in patients with metastatic germ cell tumors receiving cisplatin-based combination chemotherapy

(2017) Masatomo Nishikawa et al.   INTERNATIONAL JOURNAL OF UROLOGY

Risk and Timing of Neutropenic Events in Adult Cancer Patients Receiving Chemotherapy: The Results of a Prospective Nationwide Study of Oncology Practice

(2017) Jeffrey Crawford et al.   Journal of the National Comprehensive Cancer Network

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines†

(2016) J. Klastersky et al.   ANNALS OF ONCOLOGY

Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review

(2013) Gary H. Lyman et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy

(2010) Gary H. Lyman et al.   CANCER

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

(2010) M.S. Aapro et al.   EUROPEAN JOURNAL OF CANCER

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

(2008) Susanne Krege et al.   EUROPEAN UROLOGY